Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2009-09-28
Original SEC Filing: Click here
Webplus: SVA/20090928/6-K/2_EX-99.1/000.htm SEC Original: sinovacexh99_1.htm
Sinovac Obtains Lot Release Certificate for Its First Batch of H1N1 Vaccine BEIJING, Sept. 8 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading provider of vaccines in China, today announced that the first lot of PANFLU.1, its H1N1 vaccine, has passed the lot release process of China’s National Institute for the Control of Pharmaceutical and Biological Products and
Webplus: SVA/20090928/6-K/1/000.htm SEC Original: sinovac6k090809.htm
FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4
Company Information:
Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2009-09-28CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085
-
- Forum
- Topics
- Last Post
Leave A Comment
You must be logged in to post a comment.